RoslinCT

RoslinCT is a premier global contract development and manufacturing services organization (CDMO) specializing in Advanced Cell and Gene Therapies. With a foundation built upon groundbreaking scientific achievements, RoslinCT leverages cutting-edge technologies to drive the development of innovative human medicines. RoslinCT is committed to providing tailored CDMO solutions that enable partners to efficiently advance from development to commercialization, ultimately delivering life-saving Cell and Gene Therapies worldwide.

Located at Primary: Nine Edinburgh BioQuarter, 9 Little France Road, Edinburgh, EH16 4UX, GB and 97 South St, Hopkinton, Massachusetts 01748, US, RoslinCT boasts state-of-the-art facilities, including 22 purpose-built cGMP cell therapy processing suites. These facilities support a comprehensive range of services, including innovative process and analytical development, cGMP clinical and commercial manufacturing for various cell types in both autologous and allogeneic processes, and cGMP iPSC cell line development, gene editing, and differentiation.

RoslinCT stands at the forefront of biotechnology research, consistently pushing the boundaries of what's possible in cell and gene therapy. The company is dedicated to supporting its partners in bringing transformative therapies to patients in need. We invite the management team at RoslinCT to create a customized and exclusive company showcase and product listing on our platform to further highlight their exceptional capabilities and offerings.